Serum angiotensin-converting enzyme in multiple sclerosis

Archives of Neurology

Volumn 54, Issue 8, 1997, Pages 1012-1015

  Constantinescu, Cris S ^a,c   Goodman, David B P ^a   Grossman, Robert I ^a   Mannon, Lois J ^a   Cohen, Jeffrey A ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SPECTROPHOTOMETRY;

EID: 0030756860     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.1997.00550200068012     Document Type: Article

References (21)

1. Hooper N. Angiotensin converting enzyme: implications from molecular biology for its physiological functions. Int J Biochem, 1991;23:641-647.
2. Ehlers M, Riordan JF. Angiotensin-converting enzyme: new concepts regarding its biological role. Biochemistry. 1989;28:5311-5317.
3. Lieberman J. Elevation of angiotensin-converting-enzyme (ACE) level in sarcoidosis. Am J Med. 1975;59:365-372.
4. Goto M, Sasano M, Fuzisawa M, Okabe T, Nishizawa K. Constitutive production of angiotensin converting enzyme from rheumatoid nodule cells under serum free conditions. Ann Rheum Dis. 1992;51:741-742.
5. Veale D, Yanni G, Bresnihan B, FitzGerald O. Production of angiotensin converting enzyme by rheumatoid synovial membrane. Ann Rheum Dis. 1992;51:476-480.
6. Lieberman J, Bell DS. Serum angiotensin-converting enzyme as a marker for chronic fatigue-immune dysfunction syndrome: a comparison to serum angtotensin-converting enzyme in sarcoidosis. Am J Med. 1993;95:407-412.
7. Schweisfurth H, Schiöberg-Schiegnitz S, Kuhn W, Parusel B. Angiotensin I converting enzyme in the cerebrospinal fluid of patients with neurological diseases. Klin Wochenschr. 1987;65:955-958.
8. Luke RA, Stern BJ, Krumholz A, Johns CJ. Neurosarcoidosis: the long-term clinical course. Neurology. 1987;37:461-463.
9. Stern BJ, Krumholz A, Johns C, Scott P, Nissim J. Sarcoidosis and its neurological manifestations. Arch Neurol. 1985;42:909-917.
10. Cohen J, Constantinescu C, Grossman RI, Goodman DBP. Serum angiotensin converting enzyme levels in multiple sclerosis. Neurology. 1994;44(suppl 2): 211. Abstract.
11. Poser C, Paty D, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983;13:227-231.
12. Kurtzke J. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology. 1983;33:1444-1452.
13. Hauser S, Dawson D, Lehrich J, et al. Intensive immunosuppression in progressive multiple sclerosis: a randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH. N Engl J Med. 1983;308:173-180.
14. Holmquist B, Bünning P, Riordan JF. A continuous spectroprtotometric assay for angiotensin coverting enzyme in human serum. Anal Biochem. 1979;95:540544.
15. Grossman RI, Miki Y, Udupa JK, Samarasekera S, Polansky M, Kolson DL. Clinical correlation of multiple sclerosis lesion burden. Radiology. 1995;197(suppl 1):P275. Abstract.
16. Krupp LB, Alvarez LA, LaRocca NG, Scheinberg LC. Fatigue in multiple sclerosis. Arch Neurol. 1988;45:435-437.
17. Yotsumoto H. Longitudinal observations of serum angiotensin-converting enzyme activity in sarcoidosis with and without treatment. Chest. 1982;82:556-559.
18. Derveaux L, Demedts M, Lijnen P, Amery A. Plasma angiotensin converting enzyme in the diagnosis and monitoring of disease activity in sarcoidosis. Eur J Respir Dis. 1983;64:197-206.
19. Andreoli SP. Captopril scavenges hydrogen peroxide and reduces, but does not eliminate, oxidant-induced cell injury. Am J Physiol. 1992;264:F120-F127.
20. Schindler R, Dinarello CA, Koch K-M. Angiotensin-converting-enzyme inhibitors suppress synthesis of tumour necrosis factor and interleukin 1 by human peripheral blood mononuclear cells. Cytokine. 1995;7:526-533.
21. Constantinescu C, Ventura E, Milliard B, Rostami A. Effect of angiotensin converting enzyme inhibitor captopril on experimental autoimmune encephalomyelitis. Immunopharmacol Immunotoxicol. 1995;17:471-491.